'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Acute Ischemic Stroke to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Acute Ischemic Stroke to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Acute Ischemic Stroke Therapeutics Clinical Trials 28
Prominent Drugs 30
Clinical Trial Profile Snapshots 31
Appendix 242
Abbreviations 242
Definitions 242
Research Methodology 243
Secondary Research 243
About GlobalData 244
Contact Us 244
Disclaimer 244
Source 245
List of Tables
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials by Region, 2017* 5
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Acute Ischemic Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
Acute Ischemic Stroke Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Acute Ischemic Stroke Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Acute Ischemic Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
Acute Ischemic Stroke Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 13
Proportion of Acute Ischemic Stroke to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 15
Acute Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Acute Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Acute Ischemic Stroke to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 18
Acute Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Acute Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
List of Figures
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials by Region (%), 2017* 5
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 6
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Acute Ischemic Stroke Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
Acute Ischemic Stroke Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Acute Ischemic Stroke Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Acute Ischemic Stroke Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
Acute Ischemic Stroke Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 13
Proportion of Acute Ischemic Stroke to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 14
Acute Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Acute Ischemic Stroke Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Acute Ischemic Stroke to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 18
Acute Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Acute Ischemic Stroke Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Acute Ischemic Stroke Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Acute Ischemic Stroke Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Acute Ischemic Stroke Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 243